Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × von Hippel-Lindau Disease × cabozantinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 von Hippel-Lindau Disease 1 Thyroid Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Lung Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

palbociclib 1 lenvatinib 1 cabozantinib 1 belzutifan 1 Nivolumab 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07405164 2026-02-12

MK-6482-043

Merck Sharp & Dohme LLC

Phase 3 Not yet recruiting

Carcinoma, Renal Cell, von Hippel-Lindau Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡